Everence Capital Management Inc Eli Lilly & CO Transaction History

Everence Capital Management Inc

$1.54 Billion
Q4 2024

A detailed history of Everence Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Everence Capital Management Inc holds 22,340 shares of LLY stock, worth $17.5 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

22,340

Previous 21,650 3.19%

Holding current value

$17.5 Million

Previous $19.2 Million 10.09%

% of portfolio

1.12%

Previous 1.21%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 03, 2025	BUY	$727.2 - $932.06 $501,768 - $643,121	690 Added 3.19%	22,340 $17.2 Million
Q1 2023 Apr 04, 2023	SELL	$310.63 - $364.82 $46,594 - $54,723	-150 Reduced 0.69%	21,650 $7.44 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $1.05 Million - $1.23 Million	3,750 Added 20.78%	21,800 $7.07 Million
Q1 2022 Apr 11, 2022	BUY	$234.69 - $291.66 $682,947 - $848,730	2,910 Added 19.22%	18,050 $5.17 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $1.44 Million - $1.79 Million	-6,420 Reduced 29.78%	15,140 $4.18 Million
Q2 2021 Jul 12, 2021	BUY	$180.55 - $233.54 $1.34 Million - $1.74 Million	7,430 Added 52.58%	21,560 $4.95 Million
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $468,351 - $619,741	-3,590 Reduced 20.26%	14,130 $2.39 Million
Q3 2020 Feb 01, 2021	SELL	$146.22 - $169.13 $453,282 - $524,303	-3,100 Reduced 14.89%	17,720 $2.62 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $263,450 - $326,307	-2,464 Reduced 10.58%	20,820 $2.74 Million
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $276,975 - $323,300	-2,500 Reduced 9.7%	23,284 $2.58 Million
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $69,123 - $81,363	-621 Reduced 2.35%	25,784 $3.35 Million
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $11,471 - $12,304	140 Added 0.53%	26,405 $2.23 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $2.02 Million - $2.25 Million	26,265	26,265 $2.25 Million

Others Institutions Holding LLY

# of Institutions

4,033

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Eli Lilly & CO Transaction History